Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2022-02-03 Transaction in Own Shar…
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA Santé : déclaration de transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'DECLARATION DE TRANSACTIONS SUR ACTIONS PROPRES' (Declaration of Transactions on Own Shares). It details the number of shares bought back and the associated costs for specific dates (January 27 and 28, 2022). This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares, which maps to the 'Transaction in Own Shares' category.
2022-02-03 French
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 31/12/2021
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides a breakdown of the capital structure and voting rights ("Répartition de capital et des droits de vote") as of a specific date (31/12/2021). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a specific regulatory filing related to capital structure and ownership transparency, often required by financial market authorities (AMF in this case). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with a regulatory disclosure concerning capital structure or major shareholdings, but since it is a specific regulatory declaration about the total capital/voting rights, and not a notification of a change in a specific shareholder's stake (MRQ), it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard disclosure, or potentially a 'Share Issue/Capital Change' (SHA) if the focus is strictly on the capital base. Given the context of mandatory disclosure under AMF rules regarding the total voting rights calculation, RNS is the most appropriate general regulatory fallback for specific, non-standard disclosures not covered by other codes. However, since it explicitly details the capital composition and voting rights, it is a fundamental capital structure update. Comparing the options, SHA (Share Issue/Capital Change) covers capital structure changes, and RNS is the fallback. Since this is a periodic statement of the total capital base, RNS is safer as a general regulatory filing.
2022-01-10 French
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 30/11/2021
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides the "Répartition de capital et des droits de vote attachés aux actions au 30/11/2021" (Capital and voting rights breakdown as of November 30, 2021). This content specifically details the total number of shares, gross voting rights, and exercisable voting rights. This type of mandatory disclosure regarding capital structure and voting rights, often related to regulatory thresholds (as implied by the reference to AMF Article 223-16), fits best under the category dealing with changes in significant share ownership or capital structure notifications. While it is not a direct notification of a shareholder crossing a threshold (which would be MRQ), it is a periodic disclosure of the total capital and voting rights base. Given the options, this disclosure about the total capital and voting rights structure is most closely related to capital structure changes or major shareholding information. Since it is a formal regulatory declaration about the total capital base, it aligns well with 'Share Issue/Capital Change' (SHA) or 'Major Shareholding Notification' (MRQ). However, since it is a periodic statement of the total voting rights base, it is a fundamental capital structure disclosure. In many regulatory contexts, these periodic capital base updates are often grouped with disclosures related to significant shareholdings or capital changes. Given the explicit focus on 'Nombre de titres composant le capital' and 'droits de vote', SHA (Share Issue/Capital Change) is a strong candidate, as is MRQ (Major Shareholding Notification, which often requires knowing the total base). Since this is a declaration of the total capital base itself, SHA seems slightly more appropriate than MRQ, which usually focuses on *changes* in ownership thresholds. However, the French AMF context often links these disclosures to threshold monitoring. Let's re-evaluate the definitions. SHA is for 'new share issues, stock splits, or other capital changes'. This document reports the *current state* of capital, not necessarily a change event. MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document provides the denominator for those thresholds. Given the nature of the data (total capital and voting rights), it is a foundational piece of information often required alongside major shareholding reports. If we consider the closest fit among the provided options for a mandatory regulatory disclosure about the capital base, SHA covers the 'capital structure' aspect. If this were a notification *by* a shareholder crossing a threshold, it would be MRQ. Since it's the company reporting the total base, SHA is the most fitting category for a capital structure report, even if it's not an 'issue' or 'split'. If SHA is too narrow, RNS (Regulatory Filings) is the fallback. Given the specific nature of the content (capital and voting rights breakdown), SHA is the most precise fit among the specific categories related to capital structure.
2021-12-10 French
LNA SANTE: Renforcement capital
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated November 19, 2021, announcing significant changes to the capital structure of LNA Santé. Key elements include the signing of investment protocols, a capital increase reserved for specific investors (Nobinvest 2A, SMA BTP, SMAvie BTP, Financière Vertavienne 44), the price per share (€52.50), and a large transaction involving employee share ownership through LNA Ensemble. The text explicitly discusses fundraising, investment vehicles, capital structure changes, and the involvement of new and existing financial partners. This content directly aligns with the definition of a Capital/Financing Update (CAP). It is not an Earnings Release (ER) as it focuses on ownership structure rather than period results, nor is it a full Annual Report (10-K) or Interim Report (IR).
2021-11-19 French
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 31/10/2021
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides a breakdown of the company's capital and voting rights as of a specific date (31/10/2021). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a standard regulatory filing in France (AMF regulation). It is not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA). It specifically relates to the structure of share capital and voting power, which aligns best with general regulatory reporting or capital structure updates. Given the specific nature of reporting capital and voting rights, it is a specific regulatory disclosure. Since there isn't a perfect fit for 'Voting Rights Disclosure', and it is a formal regulatory declaration, it falls under the general 'Regulatory Filings' (RNS) category, as it is a mandatory disclosure that doesn't match the other specific categories like DVA (which is for *results* of a vote) or SHA (which is for *changes* like splits/issues). However, since it is a declaration about the *composition* of capital and voting rights, it is a fundamental piece of corporate information. Given the options, RNS is the most appropriate fallback for a specific regulatory declaration not covered elsewhere. Upon re-evaluation, this document is a mandatory disclosure of the total number of shares and voting rights, which is a key component of capital structure reporting. It is not a dividend announcement (DIV), a major shareholding notification (MRQ - which tracks specific thresholds crossed by investors), or a share issue (SHA - which announces the creation/cancellation of shares). It is a periodic statement of the total voting power. This fits best under the general Regulatory Filings (RNS) category as a mandatory disclosure.
2021-11-12 French
LNA SANTE: Chiffre d'Affaires 3ème trimestre 2021
Earnings Release Classification · 99% confidence The document is a press release dated November 4, 2021, detailing the company's financial performance for the '3ème trimestre 2021' (Third Quarter 2021). It presents key figures like 'Chiffre d'affaires Exploitation' (Operating Revenue) and provides detailed segment breakdowns and outlook confirmation. This content structure—a brief announcement focusing on key performance indicators for a specific interim period (Q3)—is characteristic of an Earnings Release (ER). It is not the full, comprehensive report (which would be an IR) nor is it a transcript (CT) or a formal annual filing (10-K). The document explicitly states the next publication date for the annual results, confirming this is an interim update. 9M 2021
2021-11-04 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.